Condition

AML/MDS clinical trials and research

As of November 12, 2026, Find a Trial lists 3 AML/MDS clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Denmark (1)). By phase: Phase 1 (2), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest AML/MDS clinical trials

StudyPhaseWhereStatusRegistered
Treatment for relapsed or refractory MDS and AML using Danvatirsen and Venetoclax Phase 1 The Bronx, New York and 1 other locations Recruiting Aug 14, 2023
Infusion of donor lymphocytes after stem cell transplantation for AML/MDS Phase 2/3 Copenhagen Recruiting Jan 17, 2023
CD123-CAR T-cell therapy for treating acute myeloid leukemia and related conditions Phase 1 Memphis, Tennessee and 1 other locations Recruiting Mar 24, 2020

All recruiting trials (3)

Related topics

Acute Myeloid LeukemiaB-ALLBPDCNMyelodysplastic SyndromesT-ALL

Quick answers

How many AML/MDS clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.